Pacific Biosciences of California, Inc. (PACB) financial statements (2021 and earlier)

Company profile

Business Address 1305 O'BRIEN DRIVE
MENLO PARK, CA 94025
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:31949102637282101
Cash and cash equivalents82301917173436
Short-term investments237198446554965
Other undisclosed cash, cash equivalents, and short-term investments   0   
Restricted cash and investments2      
Receivables171591316153
Inventory, net of allowances, customer advances and progress billings14131823161111
Inventory14131823161111
Prepaid expense   121 
Other current assets   101 
Other undisclosed current assets433(0)2 2
Total current assets:35681132102109111118
Noncurrent Assets
Operating lease, right-of-use asset3033
Property, plant and equipment253034381597
Restricted cash and investments445555 
Other noncurrent assets00001080
Total noncurrent assets:5867394229217
TOTAL ASSETS:414148170144138131125
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21222022252835
Accounts payable4879856
Accrued liabilities17131313171611
Employee-related liabilities     86
Accounts payable and other accrued liabilities11
Deferred revenue98
Debt 20    0
Other liabilities5011202
Other undisclosed current liabilities4 76710(5)
Total current liabilities:39492729343831
Noncurrent Liabilities
Long-term debt and lease obligation38421514161516
Long-term debt, excluding current maturities  1514161514
Capital lease obligations    2
Operating lease, liability3842
Liabilities, other than long-term debt221415223
Deferred revenue and credits14   
Deferred revenue22
Deferred rent credit  14
Other liabilities1   212
Derivative instruments and hedges, liabilities  00011
Other undisclosed noncurrent liabilities  111219
Total noncurrent liabilities:40442929191938
Total liabilities:78935658535870
Stockholders' equity
Stockholders' equity attributable to parent3355511486857455
Common stock0000000
Additional paid in capital1,3721,1211,096966872787736
Accumulated other comprehensive income (loss)00(0)(0)0(0)0
Accumulated deficit(1,037)(1,066)(982)(880)(788)(713)(681)
Total stockholders' equity:3355511486857455
TOTAL LIABILITIES AND EQUITY:414148170144138131125

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues79917993919361
Revenue, net93794844
Cost of revenue(46)(56)(54)(59)(47)(39)(37)
Cost of goods and services sold(46)(56)(54)(43)(35)(31)(30)
Other cost of operating revenue   (16)(12)(9)(8)
Gross profit:33352535445323
Operating expenses(137)(135)(126)(124)(115)(83)(86)
Operating loss:(104)(101)(101)(90)(71)(29)(63)
Nonoperating income (expense)36191100(0)
Investment income, nonoperating      0
Gain on contract termination3418     
Other nonoperating income (expense)211100(0)
Interest and debt expense(0)(3)(2)(3)(3)(3)(3)
Net loss:(69)(84)(103)(92)(74)(32)(66)
Other undisclosed net income (loss) attributable to parent98     (0)
Net income (loss) available to common stockholders, diluted:29(84)(103)(92)(74)(32)(66)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(69)(84)(103)(92)(74)(32)(66)
Other comprehensive loss      (0)
Comprehensive loss:(69)(84)(103)(92)(74)(32)(66)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent980(0)(0)0(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:29(84)(103)(92)(74)(32)(66)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: